Liver diseases and long non-coding RNAs: New insight and perspective

Frontiers in Medicine

Volumn 1, Issue OCT, 2014, Pages 1-1

  Quagliata, Luca ^a   Terracciano, Luigi M ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Hepatocellular carcinoma; Liver diseases; Lncrnas

Indexed keywords

EID: 85044583185     PISSN: None     EISSN: 2296858X     Source Type: Journal    
DOI: 10.3389/fmed.2014.00035     Document Type: Short Survey

References (49)

1. Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol (2012) 9:703-19. doi: 10.4161/rna.20481
2. Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet (2014) 15:7-21. doi:10.1038/nrg3606
3. He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv XW, et al. Long noncoding RNAs: novel insights into hepatocellular carcinoma. Cancer Lett (2014) 344:20-7. doi:10.1016/j.canlet.2013.10.021
4. Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem (2012) 81:145-66. doi:10.1146/annurev-biochem-051410-092902
5. Johnsson P, Lipovich L, Grander D, Morris KV. Evolutionary conservation of long non-coding RNAs; sequence, structure, function. Biochim Biophys Acta (2014) 1840:1063-71. doi:10.1016/j.bbagen.2013.10.035
6. Ghosal S, Das S, Chakrabarti J. Long noncoding RNAs: new players in the molecular mechanism for maintenance and differentiation of pluripotent stem cells. Stem Cells Dev (2013) 22:2240-53. doi:10.1089/scd.2013.0014
7. Shichino Y, Yamashita A, Yamamoto M. Meiotic long non-coding meiRNA accumulates as a dot at its genetic locus facilitated by mmi1 and plays as a decoy to lure mmi1. Open Biol (2014) 4:140022. doi:10.1098/rsob.140022
8. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, et al. MicroRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA (2006) 103:9136-41. doi:10.1073/pnas.0508889103
9. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA (2004) 101:2999-3004. doi:10.1073/pnas.0307323101
10. Burgess DJ. Non-coding RNAs: HOTTIP goes the distance. Nat Rev Genet (2011) 12:300. doi:10.1038/nrg2992
11. Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature (2011) 472:120-4. doi:10.1038/nature09819
12. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, et al. Functional demarcation of active and silent chromatin domains in human hox loci by noncoding RNAs. Cell (2007) 129:1311-23. doi:10.1016/j.cell.2007.05.022
13. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science (2010) 329:689-93. doi:10.1126/science.1192002
14. Kallen AN, Zhou XB, Xu J, Qiao C, Ma J, Yan L, et al. The imprinted h19 lncRNA antagonizes let-7 microRNAs. Mol Cell (2013) 52:101-12. doi:10.1016/j.molcel.2013.08.027
15. Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, et al. Creb up-regulates long non-coding RNA, hulc expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res (2010) 38:5366-83. doi:10.1093/nar/gkq285
16. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods (2007) 4:721-6. doi:10.1038/nmeth1079
17. Broderick JA, Zamore PD. Competitive endogenous RNAs cannot alter microRNA function in vivo. Mol Cell (2014) 54:711-3. doi:10.1016/j.molcel.2014.05.023
18. Takahashi K, Yan I, Haga H, Patel T. Long non-coding RNA in liver diseases. Hepatology (2014) 60:744-53. doi:10.1002/hep.27043
19. Gutschner T, Baas M, Diederichs S. Noncoding RNA gene silencing through genomic integration of RNA destabilizing elements using zinc finger nucleases. Genome Res (2011) 21:1944-54. doi:10.1101/gr.122358.111
20. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet (2012) 379:1245-55. doi:10.1016/S0140-6736(11)61347-0
21. Alazawi W, Cunningham M, Dearden J, Foster GR. Systematic review: outcome of compensated cirrhosis due to chronic hepatitis c infection. Aliment Pharmacol Ther (2010) 32:344-55. doi:10.1111/j.1365-2036.2010.04370.x
22. Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol (2008) 14:4300-8. doi:10.3748/wjg.14.4300
23. Schutte K, Bornschein J, Malfertheiner P. Hepatocellular carcinoma-epidemiological trends and risk factors. Dig Dis (2009) 27:80-92. doi:10.1159/000218339
24. Marquardt JU, Galle PR, Teufel A. Molecular diagnosis and therapy of hepatocellular carcinoma (hcc): an emerging field for advanced technologies. J Hepatol (2012) 56:267-75. doi:10.1016/j.jhep.2011.07.007
25. Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW. Aging of hepatitis c virus (hcv)-infected persons in the United States: a multiple cohort model of hcv prevalence and disease progression. Gastroenterology (2010) 138:513-21. doi:10.1053/j.gastro.2009.09.067
26. Teufel A, Marquardt JU, Staib F, Galle PR. Snapshot liver transcriptome in hepatocellular carcinoma. J Hepatol (2012) 56:990-2. doi:10.1016/j.jhep.2011.08.024
27. Hoshida Y, Toffanin S, Lachenmayer A, Villanueva A, Minguez B, Llovet JM. Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis (2010) 30:35-51. doi:10.1055/s-0030-1247131
28. Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet (2012) 44:694-8. doi:10.1038/ng.2256
29. Calderaro J, Labrune P, Morcrette G, Rebouissou S, Franco D, Prevot S, et al. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type i. J Hepatol (2013) 58:350-7. doi:10.1016/j.jhep.2012.09.030
30. Huang JL, Zheng L, Hu YW, Wang Q. Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma. Carcinogenesis (2014) 35:507-14. doi:10.1093/carcin/bgt405
31. Panzitt K, Tschernatsch MM, Guelly C, Moustafa T, Stradner M, Strohmaier HM, et al. Characterization of hulc, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology (2007) 132:330-42. doi:10.1053/j.gastro.2006.08.026
32. Du Y, Kong G, You X, Zhang S, Zhang T, Gao Y, et al. Elevation of highly up-regulated in liver cancer (hulc) by hepatitis b virus x protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem (2012) 287:26302-11. doi:10.1074/jbc.M112.342113
33. Xie H, Ma H, Zhou D. Plasma hulc as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed Res Int (2013) 2013:136106. doi:10.1155/2013/136106
34. Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, et al. Comparison of gene expression profiles between hepatitis b virus-and hepatitis c virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res (2002) 62:3939-44
35. Iizuka N, Oka M, Tamesa T, Hamamoto Y, Yamada-Okabe H. Imbalance in expression levels of insulin-like growth factor 2 and h19 transcripts linked to progression of hepatocellular carcinoma. Anticancer Res (2004) 24:4085-9
36. Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, et al. Long non-coding RNA malat-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol (2012) 29:1810-6. doi:10.1007/s12032-011-0004-z
37. Braconi C, Valeri N, Kogure T, Gasparini P, Huang N, Nuovo GJ, et al. Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc Natl Acad Sci USA (2011) 108:786-91. doi:10.1073/pnas.1011098108
38. Quagliata L, Matter MS, Piscuoglio S, Arabi L, Ruiz C, Procino A, et al. LncRNA HOTTIP/hoxa13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology (2013) 59:911-23. doi:10.1002/hep.26740
39. Yang Z, Zhou L, Wu LM, Lai MC, Xie HY, Zhang F, et al. Overexpression of long non-coding RNA hotair predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol (2011) 18:1243-50. doi:10.1245/s10434-011-1581-y
40. Takahashi K, Yan IK, Kogure T, Haga H, Patel T. Extracellular vesicle-mediated transfer of long non-coding RNA ror modulates chemosensitivity in human hepatocellular cancer. FEBS Open Bio (2014) 4:458-67. doi:10.1016/j.fob.2014.04.007
41. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA hotair reprograms chromatin state to promote cancer metastasis. Nature (2010) 464:1071-6. doi:10.1038/nature08975
42. Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ, Tao QF, et al. A long noncoding RNA activated by tgf-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell (2014) 25:666-81. doi:10.1016/j.ccr.2014.03.010
43. D'Angelo S, Secondulfo M, De Cristofano R, Sorrentino P. Selection and management of hepatocellular carcinoma patients with sorafenib: recommendations and opinions from an Italian liver unit. Future Oncol (2013) 9:485-91. doi:10.2217/fon.12.208
44. Troy A, Sharpless NE. Genetic "lnc"-age of noncoding RNAs to human disease. J Clin Invest (2012) 122:3837-40. doi:10.1172/JCI66645
45. Xu D, Yang F, Yuan JH, Zhang L, Bi HS, Zhou CC, et al. Long noncoding RNAs associated with liver regeneration 1 accelerates hepatocyte proliferation during liver regeneration by activating wnt/beta-catenin signaling. Hepatology (2013) 58:739-51. doi:10.1002/hep.26361
46. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med (2008) 359:378-90. doi:10.1056/NEJMoa0708857
47. van Dijk M, Thulluru HK, Mulders J, Michel OJ, Poutsma A, Windhorst S, et al. Hellp babies link a novel lincRNA to the trophoblast cell cycle. J Clin Invest (2012) 122:4003-11. doi:10.1172/JCI65171
48. Hu YW, Yang JY, Ma X, Chen ZP, Hu YR, Zhao JY, et al. A lincRNA-dynlrb2-2/gpr119/glp-1r/abca1-dependent signal transduction pathway is essential for the regulation of cholesterol homeostasis. J Lipid Res (2014) 55:681-97. doi:10.1194/jlr.M044669
49. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol (2011) 21:354-61. doi:10.1016/j.tcb.2011.04.001